Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06522256

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial

Led by ANRS, Emerging Infectious Diseases · Updated on 2025-12-04

100

Participants Needed

3

Research Sites

123 weeks

Total Duration

On this page

Sponsors

A

ANRS, Emerging Infectious Diseases

Lead Sponsor

I

INSERM SC10-US19

Collaborating Sponsor

AI-Summary

What this Trial Is About

HPVsign is a cross-sectional, non-comparative, multicenter study involving all participants included in the HPV substudy of the ANRS IPERGAY trial. The study proposes to evaluate the cumulative incidence of high-grade lesions and/or anal cancers using high-resolution anoscopy (HRA) during the HPVsign study and/or diagnosed since the end of participation in the ANRS IPERGAY trial.

CONDITIONS

Official Title

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant in the ANRS IPERGAY clinical trial who was included in the initial HPV sub-study
  • Provided informed and written signed consent
  • Has regular health insurance
Not Eligible

You will not qualify if you...

  • Participant under guardianship or curatorship
  • Participant with free State medical assistance
  • Participant who disagrees with the use of data collected during the ANRS IPERGAY trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Hôpital de la Croix Rousse - SMIT

Lyon, France, 69004

Actively Recruiting

2

Hôpital Saint-Louis - SMIT

Paris, France, 75010

Actively Recruiting

3

Hôpital Tenon - SMIT

Paris, France, 75020

Actively Recruiting

Loading map...

Research Team

F

Fatoumata Coulibaly

CONTACT

M

Mathilde Ghislain, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial | DecenTrialz